amlodipine besylate has no adverse effect on male hormonal profile

amlodipine besylate has no adverse effect on male hormonal profile

;
critical reviews in biotechnology 2016 Vol. 1 pp. -
147
noauthor2016journalamlodipine

Abstract

Amlodipine besylate is a long-acting calcium channel blocker which has proved to be very potent in the curation of elevated blood pressure. It is a relatively new antihypertensive drug which is commonly prescribed as a single oral dose. Eleven (11) male wistar rats of 250g average body weight were used to determine the effect of Amlodipine besylate on the male reproductive hormones. Three dose levels (0.5, 1.0 and 10mg/kg) were used. The rats were all sacrificed on the eight day following treatment and the serum collected was sent for hormonal assay. The results obtained showed normal values of the reproductive hormones when compared with the control. This study strongly suggests that there was no significant reduction in the values of the reproductive hormones even at the highest dose administered. It could be said that Amlodipine besylate is good for the treatment of hypertension.

Citation

ID: 247641
Ref Key: noauthor2016journalamlodipine
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
247641
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet